ArticleExperimental physiology2026
Establishment of a mouse model for ischaemic heart failure induced by coronary microembolization via left ventricular oil injection.
Article in Experimental physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Induction of ischaemic cardiomyopathy in mice without off-target effects.Experimental physiology · 2026Article
- Establishment of a mouse model for ischaemic heart failure induced by coronary microembolization via left ventricular oil injection.Experimental physiology · 2026Article
- Canadian radiology: 2025 update.Japanese journal of radiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Over the past three decades, there has been a steady increase in clinical attention to ischaemic heart failure caused by coronary microembolization. Nonetheless, a suitable mouse model for studying this condition remains limited. In the present study, we developed a mouse model of coronary microembolization-induced ischaemic heart failure by injecting corn oil into the left ventricle. After oil injection, the photoacoustic microscopy system identified an immediate obstruction of blood flow in the microvessels of the left ventricle. One day after injection of 10-60 µL oil, mice exhibited a significant decrease in left ventricular ejection fraction and fractional shortening, along with an increase in left ventricular volume during systole and elevated serum creatine kinase MB levels. Oil injection also resulted in acute cardiomyocyte necrosis, apoptosis and inflammatory infiltration. After 1 month, the mouse model demonstrated a prolonged and dose-dependent reduction in heart function, in addition to significant increases in expression of the heart failure markers BNP and MYH7 and areas of cardiac fibrosis. Correspondingly, RNA sequencing revealed 126 differentially expressed genes in the oil-injected mice, which were enriched in pathways related to myocardial contraction, vasodilatation, myocardial fibrosis and chemotactic inflammation. Notably, treatment with nitroglycerin or sacubitril-valsartan was able to mitigate the decrease of heart function in the mouse model. In conclusion, we successfully established a coronary microembolization-induced mouse model of ischaemic heart failure by left ventricular injection of oil, which exhibited high sensitivity to nitroglycerin and sacubitril-valsartan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.